Structure-activity relationships in the carcinogenicity of anticancer agents.
D000477:Alkylating Agents / Q000009:adverse effects; D000963:Antimetabolites / Q000009:adverse effects / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001388:Aziridines / Q000009:adverse effects; D004247:DNA / Q000378:metabolism; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D008745:Methylation; D008938:Mitosis / Q000187:drug effects; D009369:Neoplasms / Q000139:chemically induced*; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects; D013329:Structure-Activity Relationship
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D001388:Aziridines; D006728:Hormones; D009588:Nitrogen Mustard Compounds; D004247:DNA